A Study on Prognosis of Diffuse Glioma Based on Clinical Factors and Magnetic Resonance Imaging Radiomics
- 5 April 2024
- journal article
- research article
- Published by Elsevier in World Neurosurgery
- Vol. 186, e514-e530
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- An MRI-based radiomics signature as a pretreatment noninvasive predictor of overall survival and chemotherapeutic benefits in lower-grade gliomasEuropean Radiology, 2021
- Machine learning and radiomic phenotyping of lower grade gliomas: improving survival predictionEuropean Radiology, 2020
- A Nomogram for Predicting Individual Prognosis of Patients with Low-Grade GliomaWorld Neurosurgery, 2019
- Low-Grade Glioma Radiotherapy Treatment and TrialsNeurosurgery Clinics of North America, 2019
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryActa Neuropathologica, 2016
- The brain tissue response to surgical injury and its possible contribution to glioma recurrenceJournal of Neuro-Oncology, 2016
- IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomasActa Neuropathologica, 2015
- Low-Grade GliomasCurrent Treatment Options in Oncology, 2009
- Adult glioma incidence trends in the United States, 1977–2000Cancer, 2004
- THE LASSO METHOD FOR VARIABLE SELECTION IN THE COX MODELStatistics in Medicine, 1997